Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
368
datasets available to search
ShareScore release 0.9.0
Dataset results
368 results for “Hepatitis B virus”
Hepatitis B Virus Mutants and the Therapeutic Effect of Peginterferon Alfa-2a in HBeAg-Positive Chronic Hepatitis B
ClinicalTrials.gov study NCT01311947. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Observational Study of B-Cell Non Hodgkin Lymphomas (NHL) Associated With Hepatitis C Virus (HCV)
ClinicalTrials.gov study NCT01545544. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Genes Involved in Resistance or Susceptibility to Hepatitis B Virus
ClinicalTrials.gov study NCT00342186. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Durvalumab for Advanced Hepatocellular Carcinoma in Patients With Active Chronic Hepatitis B Virus Infection
ClinicalTrials.gov study NCT04294498. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Effect of Antiviral Therapy on Host Immune in Patients With Chronic Hepatitis B Virus(HBV) Infection
ClinicalTrials.gov study NCT01480492. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Data from: Unravelling the history of hepatitis B virus genotypes A and D infection using a full-genome phylogenetic and phylogeographic approach
Open the record for dataset details and reuse information.
Data from: Hepatitis B virus sero-profiles and genotypes in HIV-1 infected and uninfected injection and non-injection drug users from coastal Kenya
Open the record for dataset details and reuse information.
Data from: Telbivudine on IgG-associated Hypergammaglobulinemia and TGF-β1 Hyperactivity in Hepatitis B Virus-related Liver Cirrhosis
Open the record for dataset details and reuse information.
Figure 2 in Serological prevalence of hepatitis B virus (HBV) in Mardan district, Khyber Pakhtunkhwa, Pakistan
Figure 2. Typical gel photograph of HBV amplified products. Lane 1= 1 Kb molecular marker; Lane 2-7 positive samples for active HBV showing 180 bp band of hepatitis B virus; Lane = 8 negative control.
Prevalence and associated factors of hepatitis B and C virus in hemodialysis patients in Africa
<p><span><span><b>Background</b> </span></span></p> <p><span><span>Due to its invasive procedure patients on hemodialysis (HD) are at high risk of infections. Infections acquired in dialysis units can prolong hospitalization date and/or prolong illness in patients, and increase treatment cost. There are no adequate data on the prevalence of Hepatitis B virus (HBV) and Hepatitis C virus (HCV) infections in HD patients. Therefore, this study aimed to estimate the pooled prevalence and associated factors of HBV and HCV infections among HD patients in Africa.</span></span></p> <p><span><span><b>Method</b></span></span></p> <p><span><span>The databases PubMed, Medline, EMBASE, Cochrane library, web of science, African Journals Online, Science Direct, and Google Scholar were searched to identify relevant studies. The review was performed based on Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Data were extracted independently by two authors and analyzed using STATA 11. A random-effect model was fitted to estimate the pooled prevalence with their 95% confidence interval. To detect publication bias funnel plots analysis and Egger weighted regression tests were done.</span></span></p> <p><span><span><b>Results</b></span></span></p> <p><span><span>The overall pooled prevalence of HBV and HCV infection among HD patients in Africa was 9.88% (95% CI: 7.20-12.56) I<sup>2</sup>=97.9% and 23.04% (95% CI: 18.51-2757) I<sup>2</sup>=99.6%, respectively. In addition, the pooled prevalence of HBV and HCV co-infection was 7.18% (95% CI: 3.15-11.20) I<sup>2</sup>=99.6%. Duration of dialysis was found to be the contributing factor for the occurrence of HBV and HCV among HD patients (OR=1.44; 95% CI: 1.04, 2.01).</span></span></p> <p class="Default"><b>Conclusion</b></p> <p class="Default">This study showed that there is high prevalence of HBV and HCV infections in HD patients in Africa. Therefore, strict adherence to precautions of infection control measures, isolation of seropositive patients, improvement in infrastructures, adequate screening of HBV and HCV for the donated blood, and decentralized HD services is needed to minimize the risk of HBV and HCV infections in HD facilities.</p>
A hepatitis B virus (HBV) sequence variation graph improves alignment and sample-specific consensus sequence construction
Open the record for dataset details and reuse information.
Evaluation of the Efficacy of Cryotherapy Combined With Intralesional Hepatitis B Virus Vaccine Versus Either Therapy in the Treatment of Multiple Cutaneous Warts :a Comparative Study
ClinicalTrials.gov study NCT05902624. IPD Sharing: Not stated. Countries: 0. Publications: 13.
Comparison of Entecavir to Adefovir in Chronic Hepatitis B Virus (HBV) Patients With Hepatic Decompensation
ClinicalTrials.gov study NCT00065507. IPD Sharing: Not stated. Countries: 17. Publications: 0.
Antiviral Activity of Entecavir in Patients Receiving Liver Transplant Due to Chronic Hepatitis B Virus Infection
ClinicalTrials.gov study NCT00395018. IPD Sharing: Not stated. Countries: 9. Publications: 0.
Effects of Telbivudine and Tenofovir Disoproxil Fumarate Treatment on the Hepatitis B Virus DNA Kinetics in CHB
ClinicalTrials.gov study NCT00805675. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Efficacy of HEPLISAV™ Hepatitis B Virus Vaccine Compared With Engerix-B® Vaccine
ClinicalTrials.gov study NCT00435812. IPD Sharing: NO. Countries: 2. Publications: 0.
The Influence of Short-term Starvation on Hepatitis B Virus Load
ClinicalTrials.gov study NCT02364661. IPD Sharing: Not stated. Countries: 0. Publications: 2.
Study of VIR-2218 With or Without Pegylated Interferon Alpha-2a for Treatment of Chronic Hepatitis B Virus Infection
ClinicalTrials.gov study NCT04412863. IPD Sharing: NO. Countries: 6. Publications: 0.
Ledipasvir/Sofosbuvir for Hepatitis B Virus Infection
ClinicalTrials.gov study NCT03312023. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Study of ARC-520 With or Without Other Drugs Used in the Treatment of Chronic Chronic Hepatitis B Virus (HBV)
ClinicalTrials.gov study NCT02577029. IPD Sharing: Not stated. Countries: 8. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.